NCT02723669View on ClinicalTrials.gov

Relative Bioavailability of AR10 Compared to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy
Interventions
DRUG

AR10

effervescent tablet

DRUG

acetylcysteine

oral solution

Sponsors
All Listed Sponsors
lead

Arbor Pharmaceuticals, Inc.

INDUSTRY

NCT02723669 - Relative Bioavailability of AR10 Compared to Reference Product | Biotech Hunter | Biotech Hunter